US4461619A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of predicting biological activity of compounds by nucleic acid models
Assignee: Augusta University Research Institute Inc
•
Filing: 1983-03-21
•
Granted: 1984-07-24
•
Expires: 2003-03-21
Abstract
Abstract A method for determining the relationship of chemical structure to biological activity based on the topology and physiochemical properties of "cavities" or "artificial constructs" constructed from molecular models of nucleic acids, including, double-stranded DNA, double-stranded RNA and double-stranded DNA-RNA complexes. With DNA models, the second codon base is removed from each of the sixty-four possible codon-anticodon complexes in the configuration of DNA to form the cavities. Cavities were also formed between the base pairs of partially uncoiled DNA. Using the conventional physiochemical principles of hydrogen bonding and steric constraints, molecules having varying types of biological activity will fit stereochemically into certain cavities while, conversely, molecules which do not form complementary fits into a given cavity will not possess the respective biological activity. Also, the method can be utilized to determine the degree of biological activity of compounds.
Inventors
- 👤 Lawrence B. Hendry
- 👤 Edwin D. Bransome, Jr.
- 👤 Marion S. Hutson
- 👤 Lillian K. Campbell
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 16:14
CPC Classifications
G; G09; G09B; G09B23/00; G09B23/26
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
97 words
A method for determining the biological activity of a molecule, comprising the steps of: (a) preparing a model of a complementary double-stranded codon-anticodon nucleic acid complex; (b) removing the second base of the triplet sections of said codon to form in each section a space bordered by the remaining bases; (c) connecting the closest points on the upper and lower surfaces of the bases bordering the space to form a cavity; and (d) comparing the stereochemical properties of said molecule with each of the cavities to determine a complementary fit, with a fit indicating said biological activity.
Claim 2
Independent Claim
97 words
A method for determining the biological activity of a molecule, comprising the steps of: (a) preparing a model of a complementary double-stranded codon-anticodon nucleic acid complex; (b) removing the second base of the triplet sections of said codon to form in each section a space bordered by the remaining bases; (c) connecting the closest points on the upper and lower surfaces of the bases bordering the space to form a cavity; and (d) comparing the stereochemical properties of said molecule with each of the cavities to determine a complementary fit, with a fit indicating said biological activity.
Claim 3
Independent Claim
106 words
A method of predicting the biological activity of a molecule by the use of a representation of a nucleic acid, comprising the steps of: (a) removing the middle base in a codon of a nucleotide triplet of said nucleic acid; (b) analyzing the physiochemical fit of said molecule and said cavity to determine whether said fit is complementary; (c) repeating steps (a) and (b) above for a different codon if said fit is not complementary; and (d) if said fit is complementary, comparing the biological activity of a compound known to fit within said cavity with said molecule to predict the biological activity of said molecule.
Claim 4
Independent Claim
106 words
A method of predicting the biological activity of a molecule by the use of a representation of a nucleic acid, comprising the steps of: (a) removing the middle base in a codon of a nucleotide triplet of said nucleic acid; (b) analyzing the physiochemical fit of said molecule and said cavity to determine whether said fit is complementary; (c) repeating steps (a) and (b) above for a different codon if said fit is not complementary; and (d) if said fit is complementary, comparing the biological activity of a compound known to fit within said cavity with said molecule to predict the biological activity of said molecule.
Claim 5
Dependent Claim
13 words
A method as claimed in claim 2 wherein said nucleic acid is B-DNA.
Claim 6
Independent Claim
160 words
A method of designing a biologically active molecule utilizing a representation of DNA, comprising the steps of: (a) formulating a model of a proposed molecule; (b) forming the topology of a cavity created by the removal of the second base of a triplet section of the codon in said representation of DNA; (c) inserting into said cavity said model of said molecule; (d) analyzing the physiochemical fit of said molecule within said cavity to determine if said fit is complementary; (e) repeating steps (b)-(d) above for a successive number of cavities formed from the removal of the second base of a triplet section of the codon in said representation of DNA until a complementary physiochemical fit of said molecule is obtained within a cavity; and (f) comparing the biological activity of a known compound that has a physiochemical fit within the cavity into which said molecule fits with said molecule to determine the amount of biological activity of said molecules.
Claim 7
Independent Claim
160 words
A method of designing a biologically active molecule utilizing a representation of DNA, comprising the steps of: (a) formulating a model of a proposed molecule; (b) forming the topology of a cavity created by the removal of the second base of a triplet section of the codon in said representation of DNA; (c) inserting into said cavity said model of said molecule; (d) analyzing the physiochemical fit of said molecule within said cavity to determine if said fit is complementary; (e) repeating steps (b)-(d) above for a successive number of cavities formed from the removal of the second base of a triplet section of the codon in said representation of DNA until a complementary physiochemical fit of said molecule is obtained within a cavity; and (f) comparing the biological activity of a known compound that has a physiochemical fit within the cavity into which said molecule fits with said molecule to determine the amount of biological activity of said molecules.
Claim 8
Dependent Claim
24 words
A method as claimed in claim 4 wherein said analyzing step includes examining the degree of hydrogen bonding of said molecule within said cavity.
Claim 9
Dependent Claim
33 words
A method as claimed in claim 4 and further including the step of (g) manipulating the design of said molecule and repeating steps (b)-(d) until the requisite level of biological activity is obtained.
Claim 10
Independent Claim
95 words
A method of predicting the biological activity of a molecule by the use of a representation of a cavity in nucleic acid comprising the steps of: (a) preparing a model of double-stranded nucleic acid; (b) unwinding the nucleic acid model strands to a predetermined degree to form a space; (c) connecting the closest points on the upper and lower surfaces of the bases bordering the space to form a cavity; (d) comparing the stereochemical properties of said molecule with each of the cavities to determine a complementary fit, with a fit indicating said biological activity.
Claim 11
Independent Claim
95 words
A method of predicting the biological activity of a molecule by the use of a representation of a cavity in nucleic acid comprising the steps of: (a) preparing a model of double-stranded nucleic acid; (b) unwinding the nucleic acid model strands to a predetermined degree to form a space; (c) connecting the closest points on the upper and lower surfaces of the bases bordering the space to form a cavity; (d) comparing the stereochemical properties of said molecule with each of the cavities to determine a complementary fit, with a fit indicating said biological activity.
Claim 12
Dependent Claim
23 words
A method as claimed in claim 7 wherein said unwinding step includes the step of uncoiling said strands about the helix axis 26°.
References Cited (Backward Citations)
US3296714A
Cited
US3445940A
Cited
US3594924A
Cited
US3802097A
Cited
US4031635A
Cited
US4184271A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-07-24 | 1988-01-23 | 1988-07-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-07-24 | 1992-01-23 | 1992-07-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-07-24 | 1996-01-23 | 1996-07-24 | $7700.00 | Window Closed / Lapsed |